Estrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), and progesterone receptor expression status show significant heterogenicity in breast cancer and can be used to categorize the disease into distinct classes [2]. This evidence concerns the gene ERBB2 and breast cancer.